Clinical Trial Update: Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide

View source ↗

Summary

This completed pharmacoepidemiological study describes hypertensive patients treated with a fixed-dose combination of telmisartan and hydrochlorothiazide.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan/Hydrochlorothiazide (telmisartan/hydrochlorothiazide)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED